Ads attract fewer warning letters

Share this article:
Warning and untitled letters on broadcast and print DTC ads have plummeted since PhRMA's adoption of its Guiding Principles on DTC in August 2005.

In 2004, the FDA's Division of Drug Marketing, Advertising and Communications issued 13 warning and untitled letters on DTC ads. From January to August of 2005, the agency issued 17 warning and untitled letters on DTC ads. Since then, it has issued two—neither of which concerns broadcast or print, the media covered by PhRMA's voluntary code. “It reflects a significant change in attitude at DDMAC,” said John Kamp, executive director of the Coalition for Healthcare Communications.  

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.